Publication: BK polyomavirus genotypes in renal transplant recipients in the United States: A meta-analysis
Issued Date
2019-11-01
Resource Type
ISSN
17565391
17565383
17565383
Other identifier(s)
2-s2.0-85075546667
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Evidence-Based Medicine. Vol.12, No.4 (2019), 291-299
Suggested Citation
Charat Thongprayoon, Nadeen J. Khoury, Tarun Bathini, Narothama Reddy Aeddula, Boonphiphop Boonpheng, Napat Leeaphorn, Patompong Ungprasert, Jackrapong Bruminhent, Ploypin Lertjitbanjong, Kanramon Watthanasuntorn, Supavit Chesdachai, Michael A. Mao, Wisit Cheungpasitporn BK polyomavirus genotypes in renal transplant recipients in the United States: A meta-analysis. Journal of Evidence-Based Medicine. Vol.12, No.4 (2019), 291-299. doi:10.1111/jebm.12366 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51346
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
BK polyomavirus genotypes in renal transplant recipients in the United States: A meta-analysis
Other Contributor(s)
Henry Ford Health System
University of Minnesota Twin Cities
UMKC School of Medicine
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Faculty of Medicine, Siriraj Hospital, Mahidol University
University of Arizona
Indiana University School of Medicine Evansville
Mayo Clinic
University of Mississippi Medical Center
Mayo Clinic in Jacksonville, Florida
East Tennessee State University
Bassett Medical Center
University of Minnesota Twin Cities
UMKC School of Medicine
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Faculty of Medicine, Siriraj Hospital, Mahidol University
University of Arizona
Indiana University School of Medicine Evansville
Mayo Clinic
University of Mississippi Medical Center
Mayo Clinic in Jacksonville, Florida
East Tennessee State University
Bassett Medical Center
Abstract
© 2019 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd Background: In the United States, increasing ethnic diversity has been apparent. However, the epidemiology and trends of BKV genotypes remain unclear. This meta-analysis was conducted with the aim to assess the prevalence of BKV genotypes among kidney transplant (KTx) recipients in the United States. Methods: A comprehensive literature review was conducted through October 2018 utilizing MEDLINE, Embase, and Cochrane Database to identify studies that reported the prevalence of BKV subtypes and/or subgroups in KTx recipients in the United States. Pooled prevalence rates were combined using random effects, generic inverse variance method. The protocol for this study is registered with PROSPERO (no. CRD42019134582). Results: A total of eight observational studies with a total of 193 samples (urine, blood, and kidney tissues) from 188 BKV-infected KTX recipients were enrolled. Overall, the pooled estimated prevalence rates of BKV subtypes were 72.2% (95% confidence of interval [CI]: 62.7-80.0%) for subtype I, 6.8% (95% CI: 2.5-16.9%) for subtype II, 8.3% (95% CI: 4.4-15.1%) for subtype III, and 16.1% (95% CI: 10.4-24.2%) for subtype IV, respectively. While metaregression analysis demonstrated a significant positive correlation between year of study and the prevalence of BKV subtype I (slopes = +0.1023, P =.01), there were no significant correlations between year of study and percentages of BKV subtype II-IV (P >.05). Among KTx recipients with BKV subtype I, the pooled estimated percentages of BKV subgroups were 22.4% (95% CI: 13.7-34.5%) for subgroup Ia, 30.6% (95% CI: 17.7-47.5%) for subgroup Ib1, 47.7% (95% CI: 35.8-59.9%) for subgroup Ib2, and 4.1% (95% CI:1.2-13.3%) for subgroup Ic, respectively. Conclusion: BKV subtype I is the most prevalent subtype among KTx recipients in the United States and its prevalence seems to increasing overtime. Subgroup Ib2 is the most common subgroup among BKV subtype I.